Sequana Medical NV
F:2SE
Sequana Medical NV
F:2SE
Price:
0.512
EUR
Market Closed
Market Cap:
€15.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Sequana Medical NV
F:2SE
|
BE |
|
Tata Consultancy Services Ltd
BSE:532540
|
IN |
|
C
|
Compagnie d'entreprises CFE SA
F:C70
|
BE |
|
I
|
International Paper Co
DUS:INP
|
US |
|
F
|
First Mining Gold Corp
SWB:FMG
|
CA |
|
Opthea Ltd
F:UKJ2
|
AU |
|
A
|
Avery Dennison Corp
F:AV3
|
US |
|
Faurecia SE
F:FAU
|
FR |
|
L
|
Lagardere SA
SWB:LAG
|
FR |
|
IMAX China Holding Inc
OTC:IMXCF
|
CN |
|
Entra ASA
OTC:ENTOF
|
NO |
|
C
|
CGI Inc
XBER:CJ5A
|
CA |
|
C
|
Construcciones Y Auxiliar De Ferrocarriles SA
SWB:AXF1
|
ES |
|
Red Sky Energy Ltd
ASX:ROG
|
AU |
|
M
|
Microsoft Corp
SGO:MSFT
|
US |
|
G
|
Givaudan SA
XMUN:GIN
|
CH |
Wall St Price Targets
2SE Price Targets Summary
Sequana Medical NV
Sequana Medical NV
Wall Street analysts forecast 2SE stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 2SE is 2.382 EUR with a low forecast of 1.685 EUR and a high forecast of 3.153 EUR.
Lowest Forecast
Price Target
1.685
EUR
229% Upside
Average Forecast
Price Target
2.382
EUR
365% Upside
Highest Forecast
Price Target
3.153
EUR
516% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 2SE's stock price target?
Price Target
2.382
EUR
2.382
EUR
According to Wall Street analysts, the average 1-year price target for 2SE is 2.382 EUR with a low forecast of 1.685 EUR and a high forecast of 3.153 EUR.
What is the Revenue forecast for Sequana Medical NV?
Projected CAGR
462%
462%
Over the last 8 years, the compound annual growth rate for Revenue has been -28%. The projected CAGR for the next 3 years is 462%.
